Koster:

Effective in allergic rhinitis Koster (Montelukast) provides an effective and well tolerated oral treatment for allergic airway infalmmation in patients with SAR or PAR with out asthma, and in patients in whom AR is comorbid with asthma.
Supported by GINA guidelines
Dual action as a bronchodilator and anti-inflammatory
Provides significant protection against EIA
Effective in Allergic rhinitis
Improves lung function and quality of life

Dosage: As directed by the physician